全球生物模拟市场规模调查，按产品，按应用，按交付模式，按最终用途，按地区预测 2022-2028

到 2021 年，全球生物模拟市场价值约为 24 亿美元，预计在 2022-2028 年的预测期内将以超过 16.2% 的健康增长率增长。

使用计算机软件来模拟生物过程被称为生物模拟。在药物发现过程中使用称为生物模拟的预测和分析工具来预测正在进行的实验试验的结果。疾病模拟使正在开发的新药理学试剂的虚拟临床试验成为可能。生物模拟软件在药物发现和开发过程中有多种应用，因为它可以帮助製药公司更快、更便宜地找到新药。降低药物发现和开发成本的日益增长的需求以及对生命科学行业的投资增加是推动全球市场需求的因素。例如，在 2021 年 4 月发表在国家生物技术信息中心的一项研究中，利用生物模拟工具 BIOiSIM 的计算机模拟是使用众所周知的临床前体外和体内数据集进行的。该试验的目的是促进肺动脉高压疗法的再利用和对抗 COVID-19 药物的开发。因此，越来越多地使用个性化医疗和不断提高的技术进步将在未来几年刺激市场增长。然而，缺乏技能和专业知识将阻碍 2022-2028 年预测期内的市场增长。

生物模拟全球市场研究考虑的主要地区是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。由于主要市场参与者的存在、医疗保健数字化的日益普及以及慢性病患病率的上升，北美已成为全球市场份额的主要地区。另一方面，预计亚太地区将在 2022-2028 年的预测期内呈现显着的增长率。研发活动的增加以及公共和私人参与者不断增加的举措等因素将为整个亚太地区的生物模拟市场创造有利的增长前景。

本报告中包括的主要市场参与者是：

• Certara, USA
• Simulations Plus
• Dassault Systemes
• Schrodinger, Inc.
• Advanced Chemistry Development
• Chemical Computing Group ULC
• Physiomics Plc
• Rosa & Co. LLC
• Biosimulation Consulting Inc.
• Genedata AG

本研究的目的是确定近年来各个细分市场和国家/地区的市场规模，并预测未来八年的价值。本报告旨在捕捉所研究的每个地区和国家的行业的定性和定量方面。此外，它还提供了有关关键方面的详细信息，例如定义市场未来增长的驱动因素和挑战。此外，报告还应详细分析主要参与者的竞争格局和产品供应，以及微观市场中可供利益相关者投资的机会。市场的详细细分和子细分如下所述。

按产品

软件

服务

按应用程序

药物开发

药物发现

杂项

按交付模式

订阅模式

所有权模式

按最终用户

製药和生物技术公司

CRO（合同研究组织

）

监管机构

学术研究机构

按地区

北美

美国

加拿大

欧洲

英国

德国

法国

西班牙

意大利

其他欧洲

亚太地区

中国

印度

日本

澳大利亚

韩国

其他亚太地区

拉丁美洲

巴西

墨西哥

世界其他地方

此外，本研究考虑的年份是：

实际年份 - 2018 年、2019 年、2020 年

2021 年基准年

预测期 - 2022 年 至 2028 年

市场研究“全球生物模拟市场”的目标受众

主要咨询公司和顾问

大公司、中型公司、中小企业

风险投资

增值经销商 (VAR)

第三方知识提供者

投资银行家

投资者

内容

第 1 章执行摘要

• 市场快照
• 2020-2028 年全球市场和细分市场的估计和预测
  • 2020-2028 年按地区分列的生物模拟市场
  • 2020-2028 年按产品分类的生物模拟市场
  • 2020-2028 年按应用分列的生物模拟市场
  • 2020-2028 年生物模拟市场（按交付模式）
  • 生物模拟市场：按最终用途分类，2020-2028 年
• 主要趋势
• 调查方法
• 调查先决条件

第 2 章生物模拟全球市场定义和范围

• 调查目的
• 市场定义和范围
  • 调查范围
  • 工业发展
• 调查年份
• 货币兑换率

第 3 章全球生物模拟市场动态

• 生物模拟市场影响分析（2020-2028）
  • 市场驱动力
    • 降低药物发现和开发成本的需求日益增长
    • 增加对生命科学行业的投资
  • 市场挑战
    • 缺乏技能或专业知识
  • 市场机会
    • 扩大个性化医疗的使用范围
    • 不断进步的技术进步

第四章全球生物模拟市场行业分析

• 波特的 5 力模型
  • 供应商的议价能力
  • 买家的议价能力
  • 新进入者的威胁
  • 替代品的威胁
  • 竞争公司之间的敌对关係
  • 波特 5 力模型的未来方法（2018-2028）
• PEST 分析
  • 政治
  • 经济
  • 社交
  • 技术
• 招商引资模式
• 分析师的结论和建议
• 热门投资机会
• 关键成功策略

第 5 章风险评估：COVID-19 的影响

• 评估 COVID-19 对行业的整体影响
• COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球生物模拟市场：按产品分类

• 市场快照
• 全球生物模拟市场：按产品、性能潜力分析
• 2018-2028 年世界生物模拟市场、按产品估计和预测
• 生物模拟市场，细分分析
  • 软件
  • 服务

第 7 章：全球生物模拟市场：按应用分类

• 市场快照
• 世界生物模拟市场：按应用分列的性能和潜力分析
• 2018-2028 年全球生物模拟市场、估计和预测（按应用）
• 生物模拟市场，细分分析
  • 药物开发
  • 药物发现
  • 其他

第 8 章全球生物模拟市场：按交付模式

• 市场快照
• 世界生物模拟市场：交付模型的性能潜力分析
• 2018-2028 年世界生物模拟市场、按交付模型的估计和预测
• 生物模拟市场，细分分析
  • 订阅模式
  • 所有权模式

第 9 章全球生物模拟市场，按最终用途分类

• 市场快照
• 全球生物模拟市场：最终用户的表现 - 潜力分析
• 2018-2028 年世界生物模拟市场、最终用途估计和预测
• 生物模拟市场，细分分析
  • 製药公司、生物技术公司
  • CRO（合同研究组织）
  • 监管机构
  • 学术研究所

第 10 章全球生物模拟市场：区域分析

• 全球生物模拟市场，区域市场快照
• 北美
  • 美国
    • 2018-2028 年按产品分类的估计和预测
    • 按应用划分的估计和预测，2018-2028
    • 按交付模式划分的估计和预测，2018-2028 年
    • 2018-2028 年最终用户的估计和预测
  • 加拿大
• 欧洲生物模拟市场概况
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 意大利
  • 其他欧洲地区
• 亚太生物模拟市场概况
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 韩国
  • 其他亚太地区
• 拉丁美洲生物模拟市场概况
  • 巴西
  • 墨西哥
• 世界其他地区

第 11 章衝突信息

• 顶级市场策略
• 公司简介
  • Certara, USA
    • 主要信息
    • 概览
    • 财务（取决于数据可用性）
    • 产品概览
    • 近期发展状况
  • Simulations Plus
  • Dassault Systemes
  • Schrodinger, Inc.
  • Advanced Chemistry Development
  • Chemical Computing Group ULC
  • Physiomics Plc
  • Rosa & Co. LLC
  • Biosimulation Consulting Inc.
  • Genedata AG

第 12 章研究过程

• 研究过程
  • 数据挖掘
  • 分析
  • 市场估算
  • 验证
  • 出版
• 调查属性
• 调查先决条件

Global Biosimulation Market is valued at approximately USD 2.4 Billion in 2021 and is anticipated to grow with a healthy growth rate of more than 16.2% over the forecast period 2022-2028.

The use of computer software to simulate biological processes is known as biosimulation. A predictive and analytical tool called biosimulation is used in the drug discovery process to forecast the results of ongoing experimental trials. By running illness simulations, virtual clinical trials of novel pharmacological medications under development can be carried out. Biosimulation software has several uses in the pharmaceutical drug discovery and development process since it can help pharmaceutical companies find novel medications faster and more affordably. Increasing need to reduce drug discovery and development costs, as well as increasing investments in the life sciences industry, are factors that are accelerating the global market demand. For instance, in a study from April 2021 that was published in the National Center for Biotechnology Information, in silico modelling utilizing the biosimulation tool BIOiSIM was done using preclinical in vitro and in vivo datasets that were well-known. The goal of the trial was to expedite the repurposing of therapies for pulmonary hypertension and the development of COVID-19-fighting medications. Consequentially, increasing use of personalized medicine and rising technological advancements stimulate market growth in the approaching years. However, a lack of skills & expertise impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Biosimulation market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the presence of key market players, increasing adoption of digitalization in healthcare, and rising prevalence of chronic diseases. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as rising research and development activities, and rising initiatives by public and private players would create lucrative growth prospects for the Biosimulation market across the Asia Pacific region.

Major market players included in this report are:

Certara, USA

Simulations Plus

Dassault Systemes

Schrodinger, Inc.

Advanced Chemistry Development

Chemical Computing Group ULC

Physiomics Plc

Rosa & Co. LLC

Biosimulation Consulting Inc.

Genedata AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Software

Services

By Application:

Drug Development

Drug Discovery

Others

By Delivery Model:

Subscription Models

Ownership Models

By End-Use:

Pharmaceutical & Biotechnology Companies

CROs

Regulatory Authorities

Academic Research Institutions

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Biosimulation Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
  • 1.2.1. Biosimulation Market, by Region, 2020-2028 (USD Billion)
  • 1.2.2. Biosimulation Market, by Product, 2020-2028 (USD Billion)
  • 1.2.3. Biosimulation Market, by Application, 2020-2028 (USD Billion)
  • 1.2.4. Biosimulation Market, by Delivery Model, 2020-2028 (USD Billion)
  • 1.2.5. Biosimulation Market, by End-Use, 2020-2028 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Biosimulation Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Biosimulation Market Dynamics

• 3.1. Biosimulation Market Impact Analysis (2020-2028)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing need to reduce drug discovery and development costs
    • 3.1.1.2. Increasing investments in the life sciences industry
  • 3.1.2. Market Challenges
    • 3.1.2.1. Lack of skills and expertise
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increasing use of personalized medicine
    • 3.1.3.2. Rising Technological advancements

Chapter 4. Global Biosimulation Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
• 4.2. PEST Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
• 4.3. Investment Adoption Model
• 4.4. Analyst Recommendation & Conclusion
• 4.5. Top investment opportunity
• 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1.1. Assessment of the overall impact of COVID-19 on the industry
• 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Biosimulation Market, by Product

• 6.1. Market Snapshot
• 6.2. Global Biosimulation Market by Product, Performance - Potential Analysis
• 6.3. Global Biosimulation Market Estimates & Forecasts by Product, 2018-2028 (USD Billion)
• 6.4. Biosimulation Market, Sub Segment Analysis
  • 6.4.1. Software
  • 6.4.2. Services

Chapter 7. Global Biosimulation Market, by Application

• 7.1. Market Snapshot
• 7.2. Global Biosimulation Market by Application, Performance - Potential Analysis
• 7.3. Global Biosimulation Market Estimates & Forecasts by Application, 2018-2028 (USD Billion)
• 7.4. Biosimulation Market, Sub Segment Analysis
  • 7.4.1. Drug Development
  • 7.4.2. Drug Discovery
  • 7.4.3. Others

Chapter 8. Global Biosimulation Market, by Delivery Model

• 8.1. Market Snapshot
• 8.2. Global Biosimulation Market by Delivery Model, Performance - Potential Analysis
• 8.3. Global Biosimulation Market Estimates & Forecasts by Delivery Model, 2018-2028 (USD Billion)
• 8.4. Biosimulation Market, Sub Segment Analysis
  • 8.4.1. Subscription Models
  • 8.4.2. Ownership Models

Chapter 9. Global Biosimulation Market, by End-Use

• 9.1. Market Snapshot
• 9.2. Global Biosimulation Market by End-Use, Performance - Potential Analysis
• 9.3. Global Biosimulation Market Estimates & Forecasts by End-Use, 2018-2028 (USD Billion)
• 9.4. Biosimulation Market, Sub Segment Analysis
  • 9.4.1. Pharmaceutical & Biotechnology Companies
  • 9.4.2. CROs
  • 9.4.3. Regulatory Authorities
  • 9.4.4. Academic Research Institutions

Chapter 10. Global Biosimulation Market, Regional Analysis

• 10.1. Biosimulation Market, Regional Market Snapshot
• 10.2. North America Biosimulation Market
  • 10.2.1. U.S. Biosimulation Market
    • 10.2.1.1. Product breakdown estimates & forecasts, 2018-2028
    • 10.2.1.2. Application breakdown estimates & forecasts, 2018-2028
    • 10.2.1.3. Delivery model breakdown estimates & forecasts, 2018-2028
    • 10.2.1.4. End-Use breakdown estimates & forecasts, 2018-2028
  • 10.2.2. Canada Biosimulation Market
• 10.3. Europe Biosimulation Market Snapshot
  • 10.3.1. U.K. Biosimulation Market
  • 10.3.2. Germany Biosimulation Market
  • 10.3.3. France Biosimulation Market
  • 10.3.4. Spain Biosimulation Market
  • 10.3.5. Italy Biosimulation Market
  • 10.3.6. Rest of Europe Biosimulation Market
• 10.4. Asia-Pacific Biosimulation Market Snapshot
  • 10.4.1. China Biosimulation Market
  • 10.4.2. India Biosimulation Market
  • 10.4.3. Japan Biosimulation Market
  • 10.4.4. Australia Biosimulation Market
  • 10.4.5. South Korea Biosimulation Market
  • 10.4.6. Rest of Asia Pacific Biosimulation Market
• 10.5. Latin America Biosimulation Market Snapshot
  • 10.5.1. Brazil Biosimulation Market
  • 10.5.2. Mexico Biosimulation Market
• 10.6. Rest of The World Biosimulation Market

Chapter 11. Competitive Intelligence

• 11.1. Top Market Strategies
• 11.2. Company Profiles
  • 11.2.1. Certara, USA
    • 11.2.1.1. Key Information
    • 11.2.1.2. Overview
    • 11.2.1.3. Financial (Subject to Data Availability)
    • 11.2.1.4. Product Summary
    • 11.2.1.5. Recent Developments
  • 11.2.2. Simulations Plus
  • 11.2.3. Dassault Systemes
  • 11.2.4. Schrodinger, Inc.
  • 11.2.5. Advanced Chemistry Development
  • 11.2.6. Chemical Computing Group ULC
  • 11.2.7. Physiomics Plc
  • 11.2.8. Rosa & Co. LLC
  • 11.2.9. Biosimulation Consulting Inc.
  • 11.2.10. Genedata AG

Chapter 12. Research Process

• 12.1. Research Process
  • 12.1.1. Data Mining
  • 12.1.2. Analysis
  • 12.1.3. Market Estimation
  • 12.1.4. Validation
  • 12.1.5. Publishing
• 12.2. Research Attributes
• 12.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Biosimulation Market, report scope
• TABLE 2. Global Biosimulation Market estimates & forecasts by Region 2018-2028 (USD Billion)
• TABLE 3. Global Biosimulation Market estimates & forecasts by Product 2018-2028 (USD Billion)
• TABLE 4. Global Biosimulation Market estimates & forecasts by Application 2018-2028 (USD Billion)
• TABLE 5. Global Biosimulation Market estimates & forecasts by Delivery Model 2018-2028 (USD Billion)
• TABLE 6. Global Biosimulation Market estimates & forecasts by End-Use 2018-2028 (USD Billion)
• TABLE 7. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 8. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 9. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 10. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 11. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 12. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 13. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 14. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 15. Global Biosimulation Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 16. Global Biosimulation Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 17. U.S. Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 18. U.S. Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 19. U.S. Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 20. Canada Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 21. Canada Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 22. Canada Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 23. UK Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 24. UK Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 25. UK Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 26. Germany Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 27. Germany Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 28. Germany Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 29. RoE Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 30. RoE Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 31. RoE Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 32. China Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 33. China Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 34. China Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 35. India Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 36. India Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 37. India Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 38. Japan Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 39. Japan Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 40. Japan Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 41. RoAPAC Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 42. RoAPAC Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 43. RoAPAC Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 44. Brazil Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 45. Brazil Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 46. Brazil Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 47. Mexico Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 48. Mexico Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 49. Mexico Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 50. RoLA Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 51. RoLA Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 52. RoLA Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 53. Row Biosimulation Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 54. Row Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 55. Row Biosimulation Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 56. List of secondary sources, used in the study of global Biosimulation Market
• TABLE 57. List of primary sources, used in the study of global Biosimulation Market
• TABLE 58. Years considered for the study
• TABLE 59. Exchange rates considered

LIST OF FIGURES

List of figures

• FIG 1. Global Biosimulation Market, research methodology
• FIG 2. Global Biosimulation Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Biosimulation Market, key trends 2021
• FIG 5. Global Biosimulation Market, growth prospects 2022-2028
• FIG 6. Global Biosimulation Market, porters 5 force model
• FIG 7. Global Biosimulation Market, pest analysis
• FIG 8. Global Biosimulation Market, value chain analysis
• FIG 9. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
• FIG 10. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
• FIG 11. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
• FIG 12. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
• FIG 13. Global Biosimulation Market by segment, 2018 & 2028 (USD Billion)
• FIG 14. Global Biosimulation Market, regional snapshot 2018 & 2028
• FIG 15. North America Biosimulation Market 2018 & 2028 (USD Billion)
• FIG 16. Europe Biosimulation Market 2018 & 2028 (USD Billion)
• FIG 17. Asia Pacific Biosimulation Market 2018 & 2028 (USD Billion)
• FIG 18. Latin America Biosimulation Market 2018 & 2028 (USD Billion)
• FIG 19. Global Biosimulation Market, company Market share analysis (2021)